Δ9-Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism

Journal of Neuroscience

Volumn 22, Issue 11, 2002, Pages 4720-4727

  Zygmunt, Peter M ^a   Andersson, David A ^a   Högestätt, Edward D ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Calcitonin gene related peptide; Cannabinoids; Cannabinol; Cannabis; Capsaicin; Nociceptors; Pain; Receptors, sensory; Tetrahydrocannabinol

Indexed keywords

CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL; CALCIUM ION; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAICIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR; ION CHANNEL; PROTEIN KINASE C; RUTHENIUM RED; TETRAHYDROCANNABINOL; VANILLOID RECEPTOR; CALCIUM; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR CB2, RAT; CANNABINOL; DRUG RECEPTOR; PSYCHOTROPIC AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INNERVATION; CHANNEL GATING; CONCENTRATION (PARAMETERS); FEMALE; HEPATIC ARTERY; KNOCKOUT MOUSE; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SENSORY NERVE; ANIMAL; BIOASSAY; C57BL MOUSE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; INNERVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SENSORY NERVE CELL; VASODILATATION; WISTAR RAT;

AFFERENT PATHWAYS; ANIMALS; BIOLOGICAL ASSAY; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM; CANNABINOIDS; CANNABINOL; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATIC ARTERY; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS, AFFERENT; PAIN; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL; VASODILATION;

EID: 0036617759     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-11-04720.2002     Document Type: Article

References (60)

1. Amann R, Maggi CA (1991) Ruthenium red as a capsaicin antagonist. Life Sci 49:849-856.
2. Barber LA, Vasko MR (1996) Activation of protein kinase C augments peptide release from rat sensory neurons. J Neurochem 67:72-80.
3. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845-852.
4. Blumberg PM (1980) In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1. Crit Rev Toxicol 8:153-197.
5. Burstein SH (1999) The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. Pharmacol Ther 82:87-96.
6. Carlton SM, Coggeshall RE (1999) Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 820:63-70.
7. Castellano C, Cestari V, Ciamei A (2001) NMDA receptors and learning and memory processes. Curr Drug Targets 2:273-283.
8. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-824.
9. Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D (1999) A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398:436-441.
10. Cesare P, Moriondo A, Vellani V, McNaughton PA (1999) Ion channels gated by heat. Proc Natl Acad Sci USA 96:7658-7663.
11. Chavis P, Fagni L, Lansman JB, Bockaert J (1996) Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature 382:719-722.
12. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957-962.
13. Cibulsky SM, Sather WA (1999) Block by ruthenium red of cloned neuronal voltage-gated calcium channels. J Pharmacol Exp Ther 289:1447-1453.
14. Clapham DE, Runnels LW, Strubing C (2001) The TRP ion channel family. Nat Rev Neurosci 2:387-396.
15. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237.
16. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77:1660-1663.
17. Evans AR, Nicol GD, Vasko MR (1996) Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons. Brain Res 712:265-273.
18. Geppetti P, Tramontana M, Santicioli P, Del Bianco E, Giuliani S, Maggi CA (1990) Bradykinin-induced release of calcitonin gene-related peptide from capsaicin-sensitive nerves in guinea-pig atria: mechanism of action and calcium requirements. Neuroscience 38:687-692.
19. Godfraind T, Miller R, Wibo M (1986) Calcium antagonism and calcium entry blockade. Pharmacol Rev 38:321-416.
20. ++ channels. J Pharmacol Exp Ther 273:940-947.
21. 3H]-staurosporine on various protein kinases. Biochem Biophys Res Commun 171:189-195.
22. Hingtgen CM, Waite KJ, Vasko MR (1995) Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J Neurosci 15:5411-5419.
23. 2+ channels. Br J Anaesth 85:874-880.
24. 2+ channel family: comparison of mammalian ECaC1 and 2. J Physiol (Lond) 537:747-761.
25. Hogestatt ED, Zygmunt PM (2002) Cardiovascular pharmacology of anandamide. Prostaglandins Leukot Essent Fatty Acids 66:355-363.
26. Holzer P (1992) Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121:49-146.
27. Jackson DL, Hargreaves KM (1999) Activation of excitatory amino acid receptors in bovine dental pulp evokes the release of iCGRP. J Dent Res 78:54-60.
28. Kawasaki H, Takasaki K, Saito A, Goto K (1988) Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335:164-167.
29. Kessler F, Habelt C, Averbeck B, Reeh PW, Kress M (1999) Heat-induced release of CGRP from isolated rat skin and effects of bradykinin and the protein kinase C activator PMA. Pain 83:289-295.
30. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401-404.
31. Lerma J, Paternain AV, Rodriguez-Moreno A, Lopez-Garcia JC (2001) Molecular physiology of kainate receptors. Physiol Rev 81:971-998.
32. Li H, Ohishi H, Kinoshita A, Shigemoto R, Nomura S, Mizuno N (1997) Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat. Neurosci Lett 223:153-156.
33. Lopshire JC, Nicol GD (1998) The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: whole-cell and single-channel studies. J Neurosci 18:6081-6092.
34. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48:113-178.
35. Ma J (1993) Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle. J Gen Physiol 102:1031-1056.
36. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97:9561-9566.
37. Malmberg AB, Chen C, Tonegawa S, Basbaum AI (1997) Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 278:279-283.
38. McKemy DD, Neuhausser WM, Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416:52-58.
39. Mechoulam R, Hanus L (2000) A historical overview of chemical research on cannabinoids. Chem Phys Lipids 108:1-13.
40. Morisset V, Ahluwalia J, Nagy I, Urban L (2001) Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur J Pharmacol 429:93-100.
41. Olivera BM, Miljanich GP, Ramachandran J, Adams ME (1994) Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem 63:823-867.
42. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Early TJ, Dragoni I, McIntyre P, Bevan S, Patapoutian A (2002) A TRP channel that senses cold stimuli and menthol. Cell 108:705-715.
43. Pertwee RG (1988) The central neuropharmacology of psychotropic cannabinoids. Pharmacol Ther 36:189-261.
44. Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63:569-611.
45. Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP (1997) Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 121:1509-1511.
46. Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985-990.
47. Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L, Breuer A, Mechoulam R (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40:3228-3233.
48. Ruegg UT, Burgess GM (1989) Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 10:218-220.
49. 2+ channels with a high affinity for L-type channels in cerebellar granule neurons. Proc Natl Acad Sci USA 91:878-882.
50. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
51. Srivastava MD, Srivastava BI, Brouhard B (1998) Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40:179-185.
52. Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
53. Urban L, Campbell EA, Panesar M, Patel S, Chaudhry N, Kane S, Buchheit K, Sandells B, James IF (2000) In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue. Pain 89:65-74.
54. Usachev Y, Shmigol A, Pronchuk N, Kostyuk P, Verkhratsky A (1993) Caffeine-induced calcium release from internal stores in cultured rat sensory neurons. Neuroscience 57:845-859.
55. Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA (2001) Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol (Lond) 534:813-825.
56. White DM (1996) Mechanism of prostaglandin E2-induced substance P release from cultured sensory neurons. Neuroscience 70:561-565.
57. 2+ release channels: molecular mechanism and isoform selectivity. J Biol Chem 276:13810-13816.
58. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785.
59. Zygmunt PM, Hogestatt ED (1993) Calcium channels at the adrenergic neuroeffector junction in the rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol 347:617-623.
60. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.